| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.5B | $17.2B | $16.2B | $13.1B | $9.7B | $5.2B | $3.2B | $3.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.9B | $4.8B | $4.7B | $4.2B | $2.5B | $2.1B | $2.1B | $1.8B |
| Operating Income | $1.0B | $1.5B | $1.9B | $1.4B | $2.3B | $-0.6B | $3.0B | $0.3B |
| Net Income | $0.2B | $0.7B | $1.1B | $1.5B | $1.3B | $-1.0B | $2.0B | $-0.0B |
| EPS (Basic) | $0.77 | $2.42 | $3.22 | $3.52 | $2.44 | $-2.02 | $3.94 | $-0.06 |
| EPS (Diluted) | $0.76 | $2.40 | $3.19 | $3.49 | $2.41 | $-2.02 | $3.91 | $-0.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.4B | $42.2B | $42.4B | $45.7B | $40.9B | $36.5B | $33.9B | $30.2B |
| Current Assets | $4.3B | $4.4B | $4.9B | $8.2B | $6.4B | $6.0B | $4.0B | $2.5B |
| Cash & Equivalents | $2.1B | $2.4B | $2.9B | $5.9B | $4.7B | $5.1B | $2.3B | $1.5B |
| Total Liabilities | $38.1B | $38.5B | — | — | — | — | $21.1B | $19.6B |
| Current Liabilities | $3.5B | $3.4B | $3.1B | $4.5B | $3.4B | $1.9B | $3.2B | $2.9B |
| Stockholders' Equity | $2.4B | $3.0B | $3.8B | $4.8B | $6.1B | $6.5B | $7.7B | $6.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.4B | $2.7B | $1.8B | $1.4B | $-1.5B | $1.8B | $1.7B |
| Investing Cash Flow | $-1.1B | $-1.3B | $-0.7B | $2.1B | $1.5B | $2.2B | $3.5B | $-2.1B |
| Capital Expenditures | $1.1B | $1.2B | $0.9B | $0.8B | $0.5B | $0.3B | $0.7B | $1.5B |
| Financing Cash Flow | $-1.7B | $-1.6B | $-5.0B | $-3.0B | $-2.8B | $2.1B | $-4.5B | $0.4B |